A detailed history of Cerity Partners LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 7,793 shares of BIO stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,793
Previous 6,026 29.32%
Holding current value
$2.66 Million
Previous $1.65 Million 58.48%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$263.97 - $344.64 $466,434 - $608,978
1,767 Added 29.32%
7,793 $2.61 Million
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $462,211 - $584,924
-1,723 Reduced 22.24%
6,026 $1.65 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $2.09 Million - $2.41 Million
6,858 Added 769.7%
7,749 $2.68 Million
Q4 2023

Jan 26, 2024

BUY
$269.37 - $365.04 $240,008 - $325,250
891 New
891 $287,000
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $48,149 - $57,845
115 Added 13.72%
953 $456,000
Q4 2022

Feb 15, 2023

BUY
$351.71 - $456.01 $118,174 - $153,219
336 Added 66.93%
838 $352,000
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $26,818 - $36,611
65 Added 14.87%
502 $209,000
Q2 2022

Aug 10, 2022

BUY
$463.67 - $597.16 $202,623 - $260,958
437 New
437 $216,000
Q1 2022

Apr 25, 2022

SELL
$524.57 - $735.42 $194,615 - $272,840
-371 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $262,979 - $294,826
371 New
371 $282,000
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $202,859 - $221,001
-707 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $158,580 - $224,408
707 New
707 $216,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.